bmodesto-ziekenhuis-herceptin

HOW PARALLEL TRADE SUCCESSFULLY REDUCED A SHORTAGE OF AN ONCOLOGICAL MEDICINE IN THE NETHERLANDS

Int he beginning of December 2021 Hoffmann-La-Roche contacted BModesto. Roche experienced a short term shortage of…

Robin Marcus Directeur Sales Marketing

BMODESTO APPOINTS ROBIN MARCUS AS DIRECTOR OF SALES AND MARKETING

Robin Marcus has joined BModesto as director of Sales and Marketing Netherlands. In his new position,…

Cyress-barnidipine-10mg

BMODESTO IS THE NEW BRAND HOLDER OF CYRESS

BModesto is the new trademark holder of Cyress barnidipine. With this, BModesto brings Cyress back as…

Foto-bij-nieuwsbericht9

BMODESTO AGAIN NOMINATED FOR FD GAZELLEN AWARD!

For the third year in a row, BModesto has been nominated by the Financieel Dagblad for…

Foto-van-nieuwsbericht8

AWARD CEREMONY BKL TROPHY: WE ARE PROUD!

The BKL Trophy was awarded in Lelystad on Saturday evening. The trophy is awarded to a…

Foto-bij-nieuwsbericht7

BMODESTO NOMINATED FOR AN FD GAZELLEN AWARD!

We continue to grow and that does not go unnoticed. For the second year, we have…

Foto-bij-nieuwsbericht6

BMODESTO RECEIVES CERTIFICATE WORKING COMPANY LELYSTAD

During a meeting at thrift shop De Groene Sluis, BModesto was appointed Partner of Werkbedrijf Lelystad.…

Foto-bij-nieuwsbericht5

BMODESTO INTRODUCES COLECALCIFEROL OSFEROL D3

BModesto proudly introduces the product Colecalciferol Osferol-D3 – 30,000IU in collaboration with manufacturer Pharma Patent. BModesto…

Foto-bij-nieuwsartikel4

BMODESTO IS CALLING CARD FOR LELYSTAD

Pharmaceutical wholesaler opens new building on Minervaweg Only five months after the first pile was driven…

Foto-bij-nieuwsbericht2

BMODESTO FASTEST GROWING COMPANY IN THE NETHERLANDS

BModesto has been named by the Financieel Dagblad as one of the winners of the FD…